Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
341
-
Total 13F shares, excl. options
-
409M
-
Shares change
-
+16.1M
-
Total reported value, excl. options
-
$11.4B
-
Value change
-
+$507M
-
Put/Call ratio
-
3.28
-
Number of buys
-
175
-
Number of sells
-
-174
-
Price
-
$27.93
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q3 2020
431 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q3 2020.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 341 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 409M shares
of 493M outstanding shares and own 83.04% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (41M shares), VANGUARD GROUP INC (39.5M shares), JANUS HENDERSON GROUP PLC (35.9M shares), PRIMECAP MANAGEMENT CO/CA/ (33.6M shares), Aristotle Capital Management, LLC (24.1M shares), BlackRock Inc. (22M shares), WELLINGTON MANAGEMENT GROUP LLP (21.2M shares), NOMURA HOLDINGS INC (18.8M shares), STATE STREET CORP (14.5M shares), and UBS Group AG (12.7M shares).
This table shows the top 341 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.